EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access · CC BY-NC 4.0

Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer

Varun Nandakumar iD, Georges Gebrael iD, Neeraj Agarwal iD

The Oncologist · 07.10.2026 · 31 (11)

DOI: 10.1093/oncolo/oyag412 ↗

Kurz gefasst

Editorial in der Zeitschrift The Oncologist, online erschienen am 26.10.2026. Verfasst von Varun Nandakumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, United States. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PSA responseTreatment de-escalationandrogen deprivation therapymetastatic androgen pathway-modulation-sensitive/naïve prostate cancertreatment discontinuation

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, United States.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Cancer Consortium, Boston, MA 02215, United States.

ORCID-Profile: Varun Nandakumar, Georges Gebrael, Neeraj Agarwal

Zitieren

APA

Nandakumar, V., Gebrael, G., & Agarwal, N. (2026). Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer. The Oncologist, 31(11). https://doi.org/10.1093/oncolo/oyag412

Vancouver

Nandakumar V, Gebrael G, Agarwal N. Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer. The Oncologist. 2026;31(11). doi:10.1093/oncolo/oyag412

BibTeX
@article{Nandakumar2026,
  author = {Nandakumar, Varun and Gebrael, Georges and Agarwal, Neeraj},
  title = {Exceptional long-term responses in metastatic androgen pathway-modulation sensitive prostate cancer},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {11},
  doi = {10.1093/oncolo/oyag412}
}
Kostenlos starten →